Thr89
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.0.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr89  -  PRDX2 (mouse)

Site Information
THLAWINtPRkEGGL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 487517

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
'neuron, cortical'-brain ( 1 ) , 'neuron, substantia nigra'-brain ( 1 )

Upstream Regulation
Putative in vivo kinases:
CDK5 (mouse) ( 1 )
Kinases, in vitro:
CDK5 (mouse) ( 1 )
Treatments:
lithium ( 1 ) , MPTP ( 1 ) , seliciclib ( 1 )

References 

1

Qu D, et al. (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55, 37-52
17610816   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.